Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

Share Price is delayed by 15 minutes
Get Live Data
221.00    -1.00 (-0.45%)
Bid:
221.00
Ask:
232.00
Spread: 11.00 (4.977%)
Market Cap: £116.68m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Share Chart

Interim Management Statement

30 Oct 2014 07:00

RNS Number : 6537V
Microgen PLC
30 October 2014
 



microgen

www.microgen.com 30 October 2014

 

INTERIM MANAGEMENT STATEMENT

 

Microgen plc ('Microgen' or 'the Group') provides its Interim Management Statement covering the period from 1 July 2014 to the date of this announcement. Microgen released its interim results for the six months ended 30 June 2014 on 21 July 2014.

 

There have been no significant changes since 1 July 2014 in the trading or financial position of Microgen and its balance sheet remains strong. Both of the Group's businesses, Aptitude Software and Financial Systems, continue to perform satisfactorily in line with the Board's current expectations. In line with the Group's seasonal cash flow cycle and the normal variation in timing of customer receipts the Group had cash at 30 September 2014 of £34.7 million (30 June 2014: £37.9 million) and net funds of £17.7 million (30 June 2014: £20.2 million).

 

Investment has continued in the Aptitude Software business with the release of the latest version of the Aptitude technology platform in October. This software version further extends the Aptitude Big Data processing capabilities enabling users to build data-driven applications deploying Aptitude's in-memory, in-database and in-Hadoop processing. In conjunction with this release, the Aptitude Software business has entered into a partnership with Cloudera, the leading distributor of Apache Hadoop. In October, the Aptitude Software business also released the Compact Edition of the Aptitude Accounting Hub, a pre-configured Aptitude-based divisional accounting hub and sub-ledger which complements the Aptitude Revenue Recognition Engine and the Aptitude Allocation Engine released earlier in the year.

 

In August, Aptitude Software signed a contract with a large North American telecommunications company, which is anticipated to generate revenues in excess of $5 million over its expected term. Discussions are also underway with a number of other telecommunications companies related to the potentially very high volume data processing demands associated with the new IFRS 15 (customer contract revenue recognition) accounting requirements.

 

Financial Systems' wealth management product for trust and fund administration, 5Series, continues to be well received in the market with three new contracts entered into since 1 July 2014. In line with the Board's strategy, the Financial Systems' Application Management business continues to decline slowly as some legacy products/solutions approach end of life. A number of add-on acquisitions in the wealth management sector continue to be progressed, although the Board remains prudent and, as always, there can be no certainty that any acquisitions will be completed.

 

Microgen is continuously identifying and evaluating businesses and strategic investments which the Board believes may benefit from being operated as a business unit under Microgen's stewardship. The Board will maintain its prudent approach and there can be no certainty that any material acquisition will be completed.

 

Contacts

Martyn Ratcliffe, Chairman 020-7496-8100

Philip Wood, Group Finance Director

 

Lucy Delaney, FTI Consulting 020-3727-1131

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSMLBPTMBTTBFI
Date   Source Headline
6th Aug 20247:00 amRNSTransaction in Own Shares
2nd Aug 20247:00 amRNSTransaction in Own Shares
1st Aug 202410:07 amRNSTotal Voting Rights
1st Aug 20247:00 amRNSTransaction in Own Shares
31st Jul 20247:00 amRNSTransaction in Own Shares
30th Jul 20247:00 amRNSTransaction in Own Shares
25th Jul 20247:00 amRNSInterim Results
25th Jul 20247:00 amRNSTransaction in Own Shares
24th Jul 20247:00 amRNSTransaction in Own Shares
23rd Jul 20247:00 amRNSTransaction in Own Shares
18th Jul 20247:00 amRNSTransaction in Own Shares
15th Jul 20247:00 amRNSTrading Update and Notice of Results
12th Jul 20247:00 amRNSTransaction in Own Shares
8th Jul 20247:00 amRNSTransaction in Own Shares
4th Jul 20247:00 amRNSTransaction in Own Shares
3rd Jul 20247:00 amRNSTransaction in Own Shares
2nd Jul 20247:00 amRNSTransaction in Own Shares
1st Jul 20247:00 amRNSTotal Voting Rights
1st Jul 20247:00 amRNSFynapse contract win with major existing client
1st Jul 20247:00 amRNSTransaction in Own Shares
28th Jun 20247:00 amRNSTransaction in Own Shares
27th Jun 20247:00 amRNSTransaction in Own Shares
26th Jun 20247:00 amRNSNotification of Major Holdings
18th Jun 20247:00 amRNSFynapse Investor Insights Session
17th Jun 20247:00 amRNSFynapse contract win in partnership with HSO
17th Jun 20247:00 amRNSTransaction in Own Shares
6th Jun 20247:00 amRNSTransaction in Own Shares
5th Jun 20247:00 amRNSTransaction in Own Shares
3rd Jun 202411:03 amRNSTotal Voting Rights
3rd Jun 20247:00 amRNSTransaction in Own Shares
28th May 20247:00 amRNSTransaction in Own Shares
24th May 20247:00 amRNSTransaction in Own Shares
20th May 20244:38 pmRNSNotification of Major Holdings
20th May 20247:00 amRNSTransaction in Own Shares
17th May 20247:00 amRNSTransaction in Own Shares
15th May 20247:00 amRNSTransaction in Own Shares
14th May 202410:48 amRNSResult of AGM
14th May 20247:00 amRNSAGM Statement
10th May 20247:00 amRNSTransaction in Own Shares
8th May 20247:00 amRNSNotification of Major Holdings
8th May 20247:00 amRNSTransaction in Own Shares
7th May 20247:00 amRNSTransaction in Own Shares
3rd May 20247:00 amRNSTransaction in Own Shares
1st May 20244:10 pmRNSTotal Voting Rights
30th Apr 20244:46 pmRNSGrant of awards under 2020 Deferred Bonus Plan
29th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.